Select another language
Select another language

Anne Stindt

Anne Stindt

Anne Stindt

Director

Anne has experience in Market Access and Pricing & Reimbursement projects and a particular focus on the health insurance market.
She has contributed to Pricing & Reimbursement strategies, for example she led secondary research on the reimbursement situation of implantable medical devices in a global project. This was the foundation for primary research on the willingness to pay for end customers for a portfolio of implantable medical devices. Based on the analysis of the value perception and price sensitivity she and the team developed a Pricing & Reimbursement strategy for a portfolio of implantable medical devices, maximizing profitability across the portfolio.

Previously she worked for the insurance company AXA in several roles both on corporate level in the headquarter in Paris and on affiliate level in Germany. She led projects in the digital Marketing space looking to enhance the digital offering of AXA insurance. Anne was responsible for developing the Health & Medical Insurance Purchasing division at corporate level. This included the definition of global Health & Medical Purchasing strategy and implementation in the various entities (Europe, Gulf, Asia).

Anne has a Master’s degree from the ESCP-EAP business school. She completed preparatory classes with major in economics at the IPESUP after graduating from the Lycée HENRI IV in Paris. Anne is fluent in French, English and German and Portuguese.

Meet selected experts within our global team

Justin Stindt Consultants mobilizes project teams of 50+ consultants

Justin Stindt

Justin Stindt

Founder and Managing Director

Justin is an experienced Market Access strategist with a background at GlaxoSmithKline and in consulting. Justin supports pharma, biotech and medtech clients with Market Access strategy and execution. He has led hundreds of Pricing & Reimbursement projects, overseen development of Pricing & Reimbursement dossiers, led engagements with HTA bodies and conducted price negotiations on behalf of clients. Justin is fluent in English, French, German, and Spanish.

Javier Arribas Díaz

Javier Arribas Díaz

Director

With a focus on orphan drugs, Javier is experienced in advising pharmaceutical and medtech clients on market access and pricing strategies. Javier is both leading global projects and activities focused on the Spanish market such as the development of Spanish Pricing & Reimbursement strategies and dossiers. Javier has prior consulting experience at Accenture and Werfen. He studied at Kellogg School of Management in the US, did an MBA at IESE in Spain, and is proficient in Spanish and English.

Anne Stindt

Anne Stindt

Director

Anne is a health insurance specialist with a background in digital marketing and health and medical insurance purchasing at AXA where she held roles both on corporate level in the headquarter in Paris and on affiliate level in Germany. At Justin Stindt Consultants, she leads global research projects and develops Pricing & Reimbursement strategies. She is fluent in French, English, German and Portuguese and holds a Master’s degree from ESCP-EAP Business School.

Nicolas Dormois

Business Development Director

Nicolas is specialized in international commercial strategy and has experience in several Marketing & Sales roles in the industry. He is spearheading global commercial expansion as the Director of Business Development at Justin Stindt Consulting. Educated at EDHEC Business School, he brings a global business background and particular flair identifying growth opportunities. Nicolas’ role at JSC is pivotal in fostering relationships with pharma, biotech and Medtech companies worldwide and supporting them with commercial & sales strategy.

Eva Brčić

Eva Brčić

Consultant

Eva specializes in strategic market access research for pharmaceutical and biotech firms. Her projects include pricing and reimbursement analysis, research in medical information and Pricing & Reimbursement databases, and expert interviews with payers and clinical experts. Eva is fluent in English, French, and Croatian and has a Master in Management and a Bachelor’s in Psychology from the Erasmus University Rotterdam.

Camille Maréchal

Camille Maréchal

Consultant

Camille focuses on pricing and reimbursement strategies for pharmaceutical and biotech firms. Her recent projects focused e.g. on early access programs, EU-5 rebate structures and taxation systems. She also contributed to G-BA scientific advice meetings, analyzed real-world evidence interviews, and aided in lifecycle strategy development. Camille, fluent in French, Dutch, German, English and Spanish, holds a Bachelor’s degree in Business Administration from the University of St. Gallen (HSG).

Joaquim Mac Dowell Zurcher

Joaquim Mac Dowell Zurcher

Consultant

Joaquim has experience in strategic market access research for pharmaceutical and biotech companies. His projects consisted of the analysis of Pricing & Reimbursement databases and HTA appraisals in major EU markets and the US, along with the conduct of in-depth interviews with experts and payers to assess the perceived value of innovative assets and price sensitivity. Joaquim holds a Bachelor’s degree in Economics from PUC-RIO and a Master’s degree in Finance from ESSEC Business School. He is a Swiss and Brazilian citizen and speaks English, Portuguese, Spanish, and French.

Emma Berli

Consultant

Emma focuses on pricing and reimbursement strategies for pharmaceutical and biotech firms. Her projects consist of early access programs, EU-5 rebate structures and taxation systems, and analysis of Pricing & Reimbursement databases and HTA appraisals in major EU markets and the US. She also conducts in-depth interviews with experts and payers to assess the perceived value of innovative assets. Emma speaks French, English, Spanish, and German, and holds a Bachelor’s degree in Business Administration and a Master in Accounting and Corporate Finance from the University of St. Gallen (HSG).